全球生技藥品委外研發機構（CRO）市場：市場規模、佔有率、趨勢和成長分析（2026-2034）

全球生技藥品委外研發機構（CRO）市場預計將從2025年的380.2億美元成長至2034年的904.6億美元，2026年至2034年的複合年成長率（CAGR）為10.11%。隨著製藥和生物技術公司擴大將生物製藥的研究、臨床開發和法規遵循工作外包給專業的CRO，該市場正經歷顯著成長。外包委外研發機構公司能夠加速藥物開發、降低營運成本並利用先進的科學專業知識，同時保持高標準的法規遵循。對生物製藥療法日益成長的需求正在顯著推動全球醫療保健產業的市場擴張。

單株抗體、疫苗、細胞療法、基因療法和生物相似藥等領域研究活動的增加是推動產業成長的主要動力。合約研究組織（CRO）正投資於尖端實驗室技術、數位化臨床試驗管理和專業科學知識，以提高研發效率。生物技術公司、學術機構和製藥企業之間日益密切的合作，正在為整個生物製藥研究生態系統創造巨大的機會。

鑑於個人化醫療、精準治療和先進生技藥品療法在全球範圍內持續的重要性，前景依然非常​​樂觀。人工智慧、自動化和數據驅動的臨床研究有望縮短研發週期並提高法規核准率。醫療保健領域的投資增加、生技藥品研發管線的擴展以及外包策略的日益普及，將支撐全球市場的長期持續成長。

我們的報告經過精心撰寫，旨在為客戶提供有關各個行業和市場的全面而實用的見解。每份報告都包含幾個關鍵要素，以便全面了解市場狀況：

市場概覽：有關市場的詳細資訊，包括定義、分類和行業現狀。

市場動態：本節詳細分析影響市場成長的主要促進因素、限制因素、機會和挑戰。本節將檢驗技術進步、監管變化和新興趨勢等因素。

細分市場分析：市場根據產品類型、應用、最終用戶和地區等標準分類為若干清晰的細分市場。此分析揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局：我們對主要參與者進行全面評估，包括市場佔有率、產品系列、策略舉措和財務表現。我們深入分析這些主要參與者的競爭動態和關鍵策略。

市場預測：基於歷史數據和當前市場狀況，我們對特定時期內的市場規模和成長趨勢進行預測。這包括定量分析和圖表展示，以展現未來的市場軌跡。

區域分析：這包括評估每個區域的市場表現，並識別關鍵市場和區域趨勢。它有助於了解區域市場動態和商業機會。

新趨勢與機會：識別當前及未來市場趨勢、技術創新和潛在投資領域。深入分析未來市場發展和成長前景。

客製化選項：我們提供靈活的客製化服務，可根據您的特定需求量身訂做報告。這包括額外的市場細分、國家/地區特定分析、競爭對手概況、自訂資料點以及針對特定細分市場的重點分析，從而更好地支援策略決策。

目錄

第1章：引言

第2章執行摘要

第3章：市場波動因素、趨勢與框架

• 市場歷史及展望
• 滲透率和成長率預測：繪製圖
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 分析法規的影響
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球生技藥品委外研發機構（CRO）市場：依服務類型分類

• 市場分析、考量與預測
• 臨床前和分析服務
• 臨床試驗服務
• 品質和監管諮詢
• 生物資訊學和數據管理

第5章：全球生技藥品委外研發機構（CRO）市場：依階段分類

• 市場分析、考量與預測
• 臨床前
• 第一階段
• 第二階段
• 第三階段
• 第四階段

第6章：全球生技藥品委外研發機構（CRO）市場：依治療領域分類

• 市場分析、考量與預測
• 瘤
• 免疫疾病/炎症
• 感染疾病
• 罕見疾病
• 其他（心血管及代謝性疾病、神經系統疾病）

第7章：全球生技藥品CRO（委外研發機構）市場：依最終用戶分類

• 市場分析、考量與預測
• 生物製藥和生物技術公司
• 學術研究機構
• 政府機構和非營利組織

第8章 全球生技藥品委外研發機構（CRO）市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測。
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測。
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 對拉丁美洲市場的分析、洞察與預測。
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 對中東和非洲市場的分析、洞察和預測。
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈通路合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第10章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Altasciences
  • BioAgilytix Labs, LLC
  • Charles River Laboratories
  • Eurofins Scientific SE
  • Frontage Laboratories Inc
  • GenScript Biotech Corporation
  • ICON Plc
  • IQVIA Holdings Inc
  • Jubilant Biosys Limited
  • KBI Biopharma Inc
  • Labcorp Drug Development
  • Lonza Bioscience Solutions
  • Medpace Holdings Inc
  • Parexel International Corporation
  • PPD Inc.（Thermo Fisher）
  • Rentschler Biopharma SE
  • Samsung Biologics Co. Ltd
  • SGS SA
  • Syneos Health Inc
  • WuXi AppTec Co. Ltd

The global biologics contract research organizations market size is expected to reach USD 90.46 Billion in 2034 from USD 38.02 Billion in 2025, growing at a CAGR of 10.11 during 2026-2034.This market is witnessing remarkable growth as pharmaceutical and biotechnology companies increasingly outsource biologics research, clinical development, and regulatory support to specialized contract research organizations. Outsourcing enables companies to accelerate drug development, reduce operational costs, and access advanced scientific expertise while maintaining high regulatory compliance standards. Rising demand for biologic therapies is significantly strengthening market expansion across global healthcare industries.

Increasing research activities involving monoclonal antibodies, vaccines, cell therapies, gene therapies, and biosimilars are major drivers supporting industry growth. Contract research organizations are investing in advanced laboratory technologies, digital clinical trial management, and specialized scientific capabilities to improve development efficiency. Expanding collaborations between biotechnology companies, academic institutions, and pharmaceutical manufacturers are creating substantial opportunities across the biologics research ecosystem.

The future outlook remains highly favorable as personalized medicine, precision therapeutics, and advanced biologic treatments continue gaining global importance. Artificial intelligence, automation, and data-driven clinical research will improve development timelines and regulatory success rates. Rising healthcare investments, expanding biologics pipelines, and increasing outsourcing strategies will support sustained long-term market growth worldwide.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Service Type

• Pre-Clinical & Analytical Services
• Clinical Trial Services
• Quality & Regulatory Consulting
• Bioinformatics & Data Management

By Phase

• Pre-Clinical
• Phase I
• Phase II
• Phase III
• Phase IV

By Therapeutic Area

• Oncology
• Immunology & Inflammation
• Infectious Diseases
• Rare Diseases
• Others (Cardio-Metabolic, Neurology)

By End User

• Biopharmaceutical & Biotech Firms
• Academic & Research Institutes
• Government & Non-Profit Organizations

COMPANIES PROFILED

• Altasciences, BioAgilytix Labs, LLC, Charles River Laboratories, Eurofins Scientific SE, Frontage Laboratories Inc., GenScript Biotech Corporation, ICON plc, IQVIA Holdings Inc., Jubilant Biosys Limited, KBI Biopharma Inc., Labcorp Drug Development, Lonza Bioscience Solutions, Medpace Holdings Inc., Parexel International Corporation, PPD Inc. (Thermo Fisher), Rentschler Biopharma SE, Samsung Biologics Co. Ltd., SGS SA, Syneos Health Inc., WuXi AppTec Co. Ltd.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL BIOLOGICS CONTRACT RESEARCH ORGANIZATIONS MARKET: BY SERVICE TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Service Type
• 4.2. Pre-Clinical & Analytical Services Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Clinical Trial Services Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Quality & Regulatory Consulting Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Bioinformatics & Data Management Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BIOLOGICS CONTRACT RESEARCH ORGANIZATIONS MARKET: BY PHASE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Phase
• 5.2. Pre-Clinical Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Phase I Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Phase II Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Phase III Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Phase IV Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BIOLOGICS CONTRACT RESEARCH ORGANIZATIONS MARKET: BY THERAPEUTIC AREA 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Therapeutic Area
• 6.2. Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Immunology & Inflammation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Infectious Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Rare Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Others (Cardio-Metabolic, Neurology) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BIOLOGICS CONTRACT RESEARCH ORGANIZATIONS MARKET: BY END USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End User
• 7.2. Biopharmaceutical & Biotech Firms Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Academic & Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Government & Non-Profit Organizations Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL BIOLOGICS CONTRACT RESEARCH ORGANIZATIONS MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Service Type
  • 8.2.2 By Phase
  • 8.2.3 By Therapeutic Area
  • 8.2.4 By End User
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Service Type
  • 8.3.2 By Phase
  • 8.3.3 By Therapeutic Area
  • 8.3.4 By End User
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Service Type
  • 8.4.2 By Phase
  • 8.4.3 By Therapeutic Area
  • 8.4.4 By End User
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Service Type
  • 8.5.2 By Phase
  • 8.5.3 By Therapeutic Area
  • 8.5.4 By End User
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Service Type
  • 8.6.2 By Phase
  • 8.6.3 By Therapeutic Area
  • 8.6.4 By End User
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL BIOLOGICS CONTRACT RESEARCH ORGANIZATIONS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Altasciences
  • 10.2.2 BioAgilytix Labs, LLC
  • 10.2.3 Charles River Laboratories
  • 10.2.4 Eurofins Scientific SE
  • 10.2.5 Frontage Laboratories Inc
  • 10.2.6 GenScript Biotech Corporation
  • 10.2.7 ICON Plc
  • 10.2.8 IQVIA Holdings Inc
  • 10.2.9 Jubilant Biosys Limited
  • 10.2.10 KBI Biopharma Inc
  • 10.2.11 Labcorp Drug Development
  • 10.2.12 Lonza Bioscience Solutions
  • 10.2.13 Medpace Holdings Inc
  • 10.2.14 Parexel International Corporation
  • 10.2.15 PPD Inc. (Thermo Fisher)
  • 10.2.16 Rentschler Biopharma SE
  • 10.2.17 Samsung Biologics Co. Ltd
  • 10.2.18 SGS SA
  • 10.2.19 Syneos Health Inc
  • 10.2.20 WuXi AppTec Co. Ltd